Duramorph — 0.5MG, Injection, carton of 10 × 10 mL ampules

Duramorph — 0.5MG, Injection, carton of 10 × 10 mL ampules

Duramorph (morphine sulfate) is a injection for epidural; intrathecal; intravenous use. DURAMORPH is indicated for: the management of pain severe enough to require use of an opioid analgesic by intravenous administration, and for which alternative treatments are not expected to be adequate. the epidural or intrathecal management of pain without attendant loss of motor, sensory, or sympathetic function. Limitation of Use DURAMORPH is not for use in continuous microinfusion devices.

• Active ingredient or product type: MORPHINE SULFATE
• Strength/concentration: 0.5MG
• Dosage form and route: Injection, Epidural; Intrathecal; Intravenous
• Exact package presentation: carton of 10 × 10 mL ampules
• NDC/item number: 0641-6020-10
• Manufacturer: HIKMA PHARMACEUTICALS USA INC
• Storage/handling: PROTECT FROM LIGHT. stored in carton until time of use. Store at 20˚‑25˚C (68˚‑77˚F), excursions permitted to 15˚‑30˚C (59˚‑86˚F) [See USP Controlled Room Temperature].
• Status: Rx only

Important safety information: Risk of Tolerance and Myoclonic Activity: Monitor patients for unusual acceleration of neuraxial morphine, which may cause myoclonic-like spasm of lower extremities.

Refer to the current product labeling for complete indications, preparation or administration instructions, contraindications, warnings, precautions, and storage requirements.